Vasamed Company Top Management
| VSMD Stock | USD 0.0001 0.00 0.00% |
Vasamed employs about 11 people. The company is managed by 5 executives with a total tenure of roughly 48 years, averaging almost 9.0 years of service per executive, having 2.2 employees per reported executive. Reviewing how management performs at Vasamed provides context around adaptability, decision quality, and the consistency of business execution. This section is most valuable when leadership behavior is connected with profitability trends, balance-sheet quality, and the resilience of the business model.
| Paulita LaPlante CEO CEO and President and Director |
Vasamed |
Management Team Effectiveness
The company has return on total asset (ROA) of -74.1 % meaning that for every 100 dollars of assets, it generated a loss of $74.1. This is notably weak relative to sector norms.Outstanding Bonds
Vasamed may use bonds as part of its capital structure to fund operations, refinance liabilities, or support acquisitions and other long-duration investments. Longer-dated obligations can improve financing stability, but they also leave investors more exposed if the underlying business weakens before the debt matures.
| US92837TAA07 Corp BondUS92837TAA07 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View |
Holders Distribution
A large institutional presence around Vasamed deserves attention because well-resourced investors can establish or unwind positions quickly enough to change the market character of the security. The opportunity for retail investors is not to imitate blindly, but to understand how large-holder positioning may affect liquidity, volatility, and timing.
Workforce Comparison
Vasamed holds the #3 position for number of employees relative to top peers. The total workforce of Health Care industry is at this time estimated at about 327. Vasamed holds roughly 11.0 in number of employees claiming about 3% of equities under Health Care sector.
The company has Profit Margin (PM) of -56.0 %, which indicates that revenues are insufficient to cover operating costs. This is notably weak relative to sector norms. Similarly, it shows Operating Margin (OM) of -47.0 %, which means that operating expenses exceed revenue, resulting in a $47.0 loss per $100 of sales. Benchmark Summation
Operator |
This analysis covers sixty-one data points across the selected time horizon. Vasamed Price Series Summation is a cross summation of Vasamed price series and its benchmark/peer.
Notable Stakeholders
A Vasamed stakeholder is any individual or group with an interest in the outcome of the business, which is why stakeholder analysis can reveal who may influence strategy and oversight. This becomes more informative when investors want to understand not just ownership, but influence, incentives, and strategic pressure points.
| Paulita LaPlante | CEO and President and Director | Profile | |
| Roberta Dircks | CFO and VP of Fin. and Admin. | Profile | |
| Michael Schreiber | Pres CEO | Profile | |
| Wesley Peterson | Sec | Profile | |
| Daniel Bartnik | CTO Operations | Profile |
Management Information & Data Sources
Vasamed is a micro-cap company. Executive review focuses on insiders, senior management, and employee signals. Management analysis is most useful when paired with profitability, leverage, and operating trend data. CEO is Michael Schreiber with 11 employees and 5 reported executives.
Data shown for Vasamed is aggregated from periodic company reporting and market reference feeds and normalized across reporting formats. Source publication cadence can introduce delays. Insider and management fields are mapped from published filings and company disclosures.
This content is curated and reviewed by:
Rifka Kats - Member of Macroaxis Editorial BoardWorkforce Efficiency and Productivity
Workforce efficiency at Vasamed can help investors judge how effectively labor resources are being converted into revenue and profit over time. A disciplined workforce review can reveal whether execution quality is improving beneath the top-line numbers.
Vasamed Manpower Efficiency
Return on Vasamed Manpower
| Revenue Per Employee | 285K | |
| Revenue Per Executive | 626.9K | |
| Net Loss Per Employee | 265.9K | |
| Net Loss Per Executive | 585K | |
| Working Capital Per Employee | 13K | |
| Working Capital Per Executive | 28.6K |
Popular Tools for Vasamed Pink Sheet analysis
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |